Skip to main content

Table 1 Demographic and laboratory test results

From: A retrospective cohort study on prognostic factors and anti-thrombotic therapy and its correlation with disease outcome in patients of COVID-19

Parameter

Total

(mean/number)

Surviving

Non-surviving

p value

Age

55 (43–65)

52 (40–87)

60 (51–68)

 

Elderly ≥ 65

71.52

122 (22%)

76 (38%)

0.0202*

Other than elderly < 65

47.45

444 (78%)

126 (62%)

Gender (Fishers exact test)

Male

336 (59%)

132 (65%)

0.4665*

Female

230 (41%)

70 (35%)

D-dimer (mean)

2546.25

446 (1736.33)

154(3356.167)

0.0066 †

CRP (mean)

63.21125

422 (46.015)

172 (80.4075)

0.0042 †

LDH (mean)

1343.83

378 (798.6667)

120 (1889)

0.1117 †

Ferritin (mean)

490.85

184 (393.6)

59 (588.1)

0.2971 †

PT-time (mean)

16.57

230 (15.41)

111 (17.73)

0.5124 †

aPTT (mean)

43.205

217 (40.15)

108 (46.26)

0.5356 †

CT score (mean)

15.29

173 (14.07)

89 (16.51)

 

Anti-coagulant

Given

584

414 (71%)

170 (84%)

0.0414*

Not given

202

170 (29%)

32 (16%)

Anti-coagulant (Fisher’s exact test)

Enoxaparin

491

357(73%)

134 (27%)

 

Heparin

90

34 (38%)

56 (62%)

 

Aspirin

131

88 (67%)

43 (33%)

 

Clopidogrel

5

4 (80%)

1 (20%)

 

Enoxapari

491

357 (74%)

134 (57%)

0.017*

Other than Enoxaparin

226

126 (26%)

100 (43%)

Comorbidities

Present

256

161 (28%)

95 (48%)

0.0087*

Absent

512

407 (72%)

105 (52%)

 

DM

160

97 (17%)

63 (31%)

0.0307*

Other than DM

608

469 (83%)

139 (69%)

 

HTN

167

104 (18%)

63 (31%)

0.0479*

Other than HTN

601

462 (82%)

9%)

 
  1. Data are mean (IQR), mean (Percentage), number (mean) obtained by using descriptive statistics. P values comparing patients are from Student’s t test or Fisher’s exact test, where, (†) suggest application of student t-test and (*) suggests Fisher’s exact test
  2. PT partial thromboplastin time, APTT activated partial thromboplastin time